TY - JOUR
T1 - Summary of a consensus conference on heart-liver transplantation
AU - Consensus Conference participants
AU - Kobashigawa, Jon
AU - VanWagner, Lisa B.
AU - Hall, Shelley
AU - Emamaullee, Juliet
AU - Entwistle, John W.
AU - Ganger, Daniel
AU - Gebel, Howard
AU - Jeevanandam, Valluvan
AU - Kaldas, Fady
AU - Kilic, Ahmet
AU - Kittleson, Michelle
AU - Kushwaha, Sudhir
AU - Kwong, Allison
AU - Lui, George K.
AU - Motayagheni, Negar
AU - Patel, Jignesh
AU - Patel, Nikhil
AU - Pereira, Naveen
AU - Potter, Lisa
AU - Sani, Maryam
AU - Schiano, Thomas D.
AU - Shingina, Alexandra
AU - Ardehali, Abbas
AU - Baran, David
AU - Bhimaraj, Arvind
AU - Bonham, Clark Andrew
AU - Breda, Joao Roberto
AU - Chen, Sharon
AU - Czer, Lawrence
AU - Alessandro, David D.
AU - Daugherty, Tami
AU - De Marco, Teresa
AU - Emerson, Dominic
AU - Esmailian, Fardad
AU - Estep, Jerry
AU - Gaber, Osama
AU - Ebel, Noelle Hanako
AU - Harmath, Carla
AU - Heimbach, Julie
AU - Izzy, Manhal
AU - Jackson, Annette
AU - Jeevanandam, Val
AU - Kahn, Jeffrey
AU - Kamath, Patrick
AU - Kuo, Alex
AU - Lewis, Matthew
AU - Loebe, Matthias
AU - Lui, George
AU - Madsen, Joren
AU - McLean, Rhondalyn
N1 - Publisher Copyright:
© 2023 American Society of Transplantation & American Society of Transplant Surgeons
PY - 2024/3
Y1 - 2024/3
N2 - Patients with severe heart disease may have coexisting liver disease from various causes. The incidence of combined heart-liver transplant (CHLT) is increasing as more patients with congenital heart disease survive to adulthood and develop advanced heart failure with associated liver disease from chronic right-sided heart or Fontan failure. However, the criteria for CHLT have not been established. To address this unmet need, a virtual consensus conference was organized on June 10, 2022, endorsed by the American Society of Transplantation. The conference represented a collaborative effort by experts in cardiothoracic and liver transplantation from across the United States to assess interdisciplinary criteria for liver transplantation in the CHLT candidate, surgical considerations of CHLT, current allocation system that generally results in the liver following the heart for CHLT, and optimal post-CHLT management. The conference served as a forum to unify criteria between the different specialties and to forge a pathway for patients who may need dual organ transplantation. Due to the continuing shortage of available donor organs, ethical issues related to multiorgan transplantation were also debated. The findings and consensus statements are presented.
AB - Patients with severe heart disease may have coexisting liver disease from various causes. The incidence of combined heart-liver transplant (CHLT) is increasing as more patients with congenital heart disease survive to adulthood and develop advanced heart failure with associated liver disease from chronic right-sided heart or Fontan failure. However, the criteria for CHLT have not been established. To address this unmet need, a virtual consensus conference was organized on June 10, 2022, endorsed by the American Society of Transplantation. The conference represented a collaborative effort by experts in cardiothoracic and liver transplantation from across the United States to assess interdisciplinary criteria for liver transplantation in the CHLT candidate, surgical considerations of CHLT, current allocation system that generally results in the liver following the heart for CHLT, and optimal post-CHLT management. The conference served as a forum to unify criteria between the different specialties and to forge a pathway for patients who may need dual organ transplantation. Due to the continuing shortage of available donor organs, ethical issues related to multiorgan transplantation were also debated. The findings and consensus statements are presented.
KW - criteria
KW - heart transplantation
KW - liver transplantation
KW - outcomes
UR - http://www.scopus.com/inward/record.url?scp=85181052878&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85181052878&partnerID=8YFLogxK
U2 - 10.1016/j.ajt.2023.12.002
DO - 10.1016/j.ajt.2023.12.002
M3 - Article
C2 - 38072122
AN - SCOPUS:85181052878
SN - 1600-6135
VL - 24
SP - 380
EP - 390
JO - American Journal of Transplantation
JF - American Journal of Transplantation
IS - 3
ER -